🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact The Pharmacist's Role: How Community Pharmacies in Ireland and the UK Are Adapting as Patients Bypass High-Street Stores for Direct Delivery GLP-1 Therapeutics and Clinical Research Updates: Brain Reward Mapping, Oral Small Molecules, and Triple-Agonist Horizons Rinn Pharma & Biopharma Joins NordicPharmaTrain Network to Accelerate European Research & Advanced Manufacturing Markets Surge as August Opens: $400B Big Pharma Merger Speculation & AstraZeneca Deal Talks Grab Global Headlines Trump’s September Visit to Ireland: Agenda, Economic Policy Evaluation & U.S.-Irish Trade Implications Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact The Pharmacist's Role: How Community Pharmacies in Ireland and the UK Are Adapting as Patients Bypass High-Street Stores for Direct Delivery GLP-1 Therapeutics and Clinical Research Updates: Brain Reward Mapping, Oral Small Molecules, and Triple-Agonist Horizons Rinn Pharma & Biopharma Joins NordicPharmaTrain Network to Accelerate European Research & Advanced Manufacturing Markets Surge as August Opens: $400B Big Pharma Merger Speculation & AstraZeneca Deal Talks Grab Global Headlines Trump’s September Visit to Ireland: Agenda, Economic Policy Evaluation & U.S.-Irish Trade Implications
Updated 04 Jul 2026 · HPRA open data

Irish Medicines Database

Every medicine authorised for the Irish market — 10,165 products with active substances, licence holders, dosage forms and prescription status.

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0–9
550 medicines starting with “M”
MedicineActive substanceLicence holderStatus
Metoject 7.5 mg solution for injection in pre-filled pen
PPA0465/436/006
Methotrexate PCO Manufacturing Ltd.
Metopirone 250 mg soft capsules
PA23005/001/001
Metyrapone Esteve Pharmaceuticals S.A. Marketed
Metronidazole 5 mg/ml solution for infusion
PA0736/002/001
Metronidazole B. Braun Melsungen AG Marketed
Metronidazole 5 mg/mL solution for infusion
PA1122/041/001
Metronidazole Noridem Enterprises Limited Not marketed
Metvix 160 mg/g cream
PA22743/010/001
METHYL AMINOLEVULINATE HYDROCHLORIDE Galderma International Marketed
Mevlyq 0.44 mg/mL solution for injection
EU/1/23/1789/001
Eribulin mesylate Yes Pharmaceutical Development Services GmbH
Mezavant XL 1200 mg gastro-resistant, prolonged release tablets
PA23211/004/001
Mesalazine Takeda Pharmaceuticals International AG Ireland Branch Marketed
Mezavant XL 1200 mg gastro-resistant, prolonged release tablets
PPA0465/289/001
Mesalazine PCO Manufacturing Ltd.
Mezavant XL 1200 mg gastro-resistant, prolonged release tablets
PPA1463/093/001
Mesalazine IMED Healthcare Ltd.,
Mezavant XL 1200 mg gastro-resistant, prolonged release tablets
PPA2306/023/001
Mesalazine Originalis B.V.
Miacalcic 100 IU/ml solution for injection and infusion
PA22644/004/001
Calcitonin Essential Pharma (M) Limited Not marketed
Miacalcic 50 IU/ml solution for injection and infusion
PA22644/004/002
Calcitonin Essential Pharma (M) Limited Not marketed
MIBG (123I) 74 MBq/mL solution for injection
PA0690/005/001
Iobenguane Curium Netherlands B.V. Marketed
Micardis 20 mg tablets
EU/1/98/090/009-012
Telmisartan Boehringer Ingelheim International GmbH
Micardis 40 mg tablets
EU/1/98/090/001-004
Telmisartan Boehringer Ingelheim International GmbH
Micardis 80 mg tablets
EU/1/98/090/005-008
Telmisartan Boehringer Ingelheim International GmbH
MicardisPlus 40 mg/12.5 mg tablets
EU/1/02/213/001-005
Telmisartan, Hydrochlorothiazide Boehringer Ingelheim International GmbH
MicardisPlus 80 mg/12.5 mg tablets
EU/1/02/213/006-010
Telmisartan, Hydrochlorothiazide Boehringer Ingelheim International GmbH
MicardisPlus 80 mg/25 mg tablets
EU/1/02/213/17-23
Telmisartan, Hydrochlorothiazide Boehringer Ingelheim International GmbH
Micrazym 10000 units gastro-resistant capsules, hard
PA22871/030/001
Pancreatin Azure Pharmaceuticals Ltd. Not marketed
Micrazym 25000 units gastro-resistant capsules, hard
PA22871/030/002
Pancreatin Azure Pharmaceuticals Ltd. Not marketed
Microlax Rectal Solution Sodium Citrate 450 mg/5 ml Sodium Lauryl Sulphoacetate 45 mg/5 ml
PA23490/017/001
Sodium citrate, Sodium lauryl sulfoacetate JNTL Consumer Health I (Ireland) Limited Marketed
Microlite 100 microgram/20 microgram coated tablets
PA1410/090/001
Levonorgestrel, Ethinylestradiol Bayer Limited Not marketed
Midazolam 1 mg/ml solution for injection in pre-filled syringe
PA1968/017/001
Midazolam Laboratoire Aguettant Marketed
Midazolam 1 mg/ml Solution for Injection or Infusion
PA2315/063/001
Midazolam Accord Healthcare Ireland Ltd. Marketed
Midazolam 1 mg/ml solution for injection/infusion
PA2165/012/002
Midazolam AS Kalceks
Midazolam 1 mg/ml solution for injection/infusion
PA1968/017/002
Midazolam Laboratoire Aguettant Marketed
Midazolam 1 mg/ml solution for injection/infusion in pre-filled syringe
PA2315/220/001
Midazolam Accord Healthcare Ireland Ltd. Not marketed
Midazolam 2 mg/ml Solution for injection or infusion
PA2315/063/005
Midazolam Accord Healthcare Ireland Ltd. Marketed
Midazolam 5 mg/ml Solution for injection or infusion
PA2315/063/006
Midazolam Accord Healthcare Ireland Ltd. Marketed
Midazolam 5 mg/ml Solution for Injection or Infusion
PA2315/063/002
Midazolam Accord Healthcare Ireland Ltd. Not marketed
Midazolam 5 mg/ml solution for injection/infusion
PA2165/012/001
Midazolam AS Kalceks
Midazolam 5 mg/ml solution for injection/infusion
PA1968/017/003
Midazolam Laboratoire Aguettant Marketed
Midazolam Rowa 10 mg oromucosal solution
PA0074/099/004
Midazolam Rowa Pharmaceuticals Limited, Marketed
Midazolam Rowa 2.5 mg oromucosal solution
PA0074/099/001
Midazolam Rowa Pharmaceuticals Limited, Marketed
Midazolam Rowa 5 mg oromucosal solution
PA0074/099/002
Midazolam Rowa Pharmaceuticals Limited, Marketed
Midazolam Rowa 7.5 mg oromucosal solution
PA0074/099/003
Midazolam Rowa Pharmaceuticals Limited, Marketed
Midodrine Hydrochloride Aspire 2.5 mg tablets
PA23142/008/001
Midodrine hydrochloride Aspire Pharma (Malta) Limited Not marketed
Midodrine Hydrochloride Aspire 5 mg tablets
PA23142/008/002
Midodrine hydrochloride Aspire Pharma (Malta) Limited Not marketed
Midodrine Tillomed 2.5 mg tablets
PA23169/002/001
Midodrine hydrochloride Tillomed Pharma GmbH Not marketed
Midodrine Tillomed 5 mg tablets
PA23169/002/002
Midodrine hydrochloride Tillomed Pharma GmbH Not marketed
Midon 2.5 mg tablets
PA2239/016/001
Midodrine hydrochloride CHEPLAPHARM Arzneimittel GmbH Marketed
Midon 2.5 mg tablets
PPA1463/160/001
Midodrine hydrochloride IMED Healthcare Ltd.,
Midon 2.5 mg tablets
PPA23080/024/001
Midodrine hydrochloride Merit Pharmaceuticals Limited
Midon 2.5 mg Tablets
PPA2306/032/001
Midodrine hydrochloride Originalis B.V.
Midon 5 mg tablets
PA2239/016/002
Midodrine hydrochloride CHEPLAPHARM Arzneimittel GmbH Marketed
Midon 5 mg tablets
PPA23080/024/002
Midodrine hydrochloride Merit Pharmaceuticals Limited
Midon 5 mg tablets
PPA2306/029/001
Midodrine hydrochloride Originalis B.V.
Mifegyne 200 mg tablets
PA22946/001/001
Mifepristone EXELGYN
Mifegyne 600 mg tablets
PA22946/001/002
Mifepristone EXELGYN
3 4 5 6 7 8 9
Cite this database

Priya Life Science (2026). Irish Medicines Database. Available at: https://priyalifescience.com/medicines (Accessed: 15 August 2026).

Data: Health Products Regulatory Authority (HPRA) open dataset (“Authorised or Transfer Pending Products”), licensed CC BY 4.0, refreshed daily. Regulatory information only — not medical advice.